+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Norvir"

Global HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
Norvir SEC - API Insight, 2022 - Product Thumbnail Image

Norvir SEC - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Norvir SEC- Drug Insight, 2019 - Product Thumbnail Image

Norvir SEC- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Norvir (ritonavir) is an antiretroviral drug used to treat HIV infection and AIDS. It is a protease inhibitor, which works by blocking the action of the HIV protease enzyme, preventing the virus from replicating. Norvir is used in combination with other antiretroviral drugs to treat HIV infection and AIDS. It is also used to prevent HIV infection in people who are at high risk of becoming infected. Norvir is part of the Infectious Diseases Drugs market, which includes drugs used to treat a wide range of infectious diseases, including HIV/AIDS, malaria, tuberculosis, and other viral, bacterial, and fungal infections. These drugs are used to treat both acute and chronic infections, and can be administered orally, intravenously, or topically. The companies in the Norvir market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Show Less Read more